Skip to main content

Rebecca A Previs

Adjunct Assistant Professor in the Department of Obstetrics and Gynecology
Obstetrics and Gynecology, Gynecologic Oncology
Division of Gynecologic Oncolo, DUMC Box 3079, Durham, NC 27710

Current Appointments & Affiliations


Adjunct Assistant Professor in the Department of Obstetrics and Gynecology · 2022 - Present Obstetrics and Gynecology, Gynecologic Oncology, Obstetrics and Gynecology

In the News


Published April 8, 2022
Findings Support Retesting for MMRD at Uterine Cancer Recurrence
Published December 1, 2021
Dissecting Disparities in Cancer Outcomes
Published May 3, 2019
Urogynecology, Gynecologic Oncology Faculty Receive Research Awards

View All News

Recent Publications


Data from Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian Cancer

Other · December 11, 2025 <div>AbstractBackground:<p>Differential access to quality care is associated with racial disparities in ovarian cancer survival. Few studies have examined the association of multiple healthcare access (HCA) dimensions with racial dispar ... Full text Cite

Supplementary Figure from Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian Cancer

Other · December 11, 2025 Supplementary Figure from Associations of Healthcare Affordability, Availability, and Accessibility with Quality Treatment Metrics in Patients with Ovarian Cancer ... Full text Cite

Data from Healthcare Access Domains Mediate Racial Disparities in Ovarian Cancer Treatment Quality in a US Patient Cohort: A Structural Equation Modelling Analysis

Other · November 26, 2025 <div>AbstractBackground:<p>Ovarian cancer survival disparities have persisted for decades, driven by lack of access to quality treatment. We conducted structural equation modeling (SEM) to define latent variables representing three heal ... Full text Cite
View All Publications

Recent Grants


Duke-UNC-Wash U Partnership for Early Phase Clinical Trials in Cancer

Clinical TrialSignificant Contributor · Awarded by National Institutes of Health · 2014 - 2023

Use of an oncolytic adenovirus to promote anti-tumor T-cell responses in ovarian cancer

ResearchMentor · Awarded by Foundation for Women's Cancer · 2022 - 2023

Adrenergic signaling inhibition to enhance the immunogenicity of the ovarian tumor microenvironment prior to PD-1 checkpoint therapy

ResearchPrincipal Investigator · Awarded by Ponce Health Sciences University · 2020 - 2022

View All Grants

Education


University of Virginia, School of Medicine · 2009 M.D.